Non-genomic cell growth inhibition by progesterone. cell cycle retardation and induction of cell death

Anticancer Res. 2004 Nov-Dec;24(6):3749-55.

Abstract

Background: Non-genomic mechanisms have been proposed to play a role in progesterone-dependent cell growth inhibition.

Materials and methods: The human cell line C-4I, derived from a squamous carcinoma of the uterine cervix, was progesterone receptor-negative. The culture medium contained 10% (v/v) fetal calf serum and the cells, growing in monolayer, were exposed to various progesterone concentrations. Flow cytometry and morphometry were employed to assess the effects.

Results: Progesterone caused a concentration-dependent growth inhibition with an IC50 value of 2.06 +/- 0.46 microM (mean value +/- SEM, n = 4). At 320 microM no viable and attached cells were left. Two mechanisms appeared to be responsible for the effect. Firstly, the cells accumulated in the G1/G0-phase indicating a cell cycle-specific arrest. Secondly, progesterone induced cell death with apoptosis and necrosis. Morphometric analysis showed that progesterone caused a marked reduction in the nuclear size, compatible with apoptosis.

Conclusion: The present results show that progesterone exerts non-genomic effect(s) by reducing the input of and accelerating the exit of cells from the C-4I cell population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology*
  • Cell Cycle / drug effects
  • Cell Growth Processes / drug effects
  • Female
  • Growth Inhibitors / pharmacology
  • Humans
  • Progesterone / pharmacology*
  • Receptors, Progesterone / biosynthesis
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / metabolism
  • Uterine Cervical Neoplasms / pathology*

Substances

  • Growth Inhibitors
  • Receptors, Progesterone
  • Progesterone